Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fentanyl + ketorolac is a multimodal analgesic combination utilized as the standard of care for managing postoperative pain in pediatric patients, specifically those undergoing bilateral myringotomy with tympanostomy tube (BMT) placement. This regimen combines fentanyl, a potent synthetic mu-opioid receptor agonist that provides rapid systemic analgesia, with ketorolac, a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes to reduce prostaglandin synthesis. In a Phase 4 clinical trial conducted by the University of South Alabama, this intramuscular combination is used as the active comparator to evaluate the efficacy and opioid-sparing potential of the Nerve of Arnold block regional anesthesia technique. The combination aims to provide effective pain control while balancing the side effects associated with opioid use in children.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fentanyl + ketorolac (University of South Alabama).